Stock screenerAll disclosures →
EDGAR →
INDV
Conviction 58HealthcareScan · Mon, Aug 10, 2026INDV$38.48-0.89%
ResistanceSupportVol 14Insider buyInsider sellVol MA14 2.95M
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest +300.00%· 4 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price38.48
Change-0.89%
Gap-0.66%
Rel volume3.32×
Avg volume2.57M
Avg $ vol99.76M
SMA 2039.66
SMA 5039.21
SMA 20034.88
Price vs 50-1.86%
Price vs 200+10.32%
MA stackmixed
50/200 cross—
Supertrenddown · 42.08
RSI (14)45
MACD hist-0.24
MACD cross—
Stoch %K / %D46 / 49
ADX (14)18
+DI / −DI15 / 21
RSI divergenceBearish
MACD divergence—
ATR %+4.14%
ADR %4.06%
52w high41.83
52w low22.00
From 52w high-8.02%
Above 52w low+74.89%
New 52w highNo
SqueezeOff
Bollinger width12.00%
%B0.25
Donchian pos44.63%
Donchian high41.84
Donchian low35.76
AVWAP (52w high)39.60
vs AVWAP high-2.85%
AVWAP (52w low)32.72
vs AVWAP low+17.58%
OBV trendDown
Chaikin MF (20)-0.13
Today vs 20d3.32×
Avg vol (14d)2.95M
Avg vol (20d)2.57M
Avg $ vol (20d)99.76M
Market cap4.54B
RS 3m (vs SPY)-7.67%
RS 6m (vs SPY)-1.43%
RS line new highNo
Trend template6/8
Technical rank53.2
1 week+2.96%
1 month-5.00%
3 months-2.59%
6 months+11.98%
1 year+74.49%
YTD+7.68%
P/E21.62
P/B-21.83
P/S3.66
P/FCF-48.82
EPS1.64
Div yield—
ROE-100.96%
ROA17.03%
Debt/Eq-2.34
Current0.84
EV/EBITDA17.67
Gross margin80.23%
Net margin16.95%
Rev growth4.29%
EPS growth2900.00%
Price target50.75
Target upside31.90%
Analyst ratingBuy
Institutional116.62%
Ent. value4.81B
Revenue343M
Net income122M
Gross profit294M
Free cash flow-93M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out121.92M
Employees838
ListedWed, Dec 24, 2014
Free float114.59M
Float %91.8%
Short interest11.28M
Days to cover7.6d
Short volume55.7%
Squeeze score70 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.15 vs $0.97
Last surprise+18.6% beat
Setup gradeC
Conviction58 / 100
Pattern quality—
Tech rank53.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance42.33
Support36.70
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in INDV
No recent disclosed trades by Congress in INDV. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in INDV · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Anderson Woodrow D Chief Accounting Officer · Common Stock · 2026-08-05 | Buy | 1.5K | $54K | 2026-08-05 | 2026-08-05 |
Heidbreder Christian Chief Scientific Officer · Common Stock · 2026-07-10 | Sell | 18.59K | $765K | 2026-07-10 | 2026-07-13 |
Preblick Ryan Chief Financial Officer · Common Stock · 2026-06-08 | Sell | 36K | $1.4M | 2026-06-08 | 2026-06-10 |
Stejbach Mark Director · Common Stock · 2026-05-13 | Grant | 6.52K | $0 | 2026-05-13 | 2026-05-14 |
Thompson Juliet Director · Common Stock · 2026-05-13 | Grant | 6.52K | $0 | 2026-05-13 | 2026-05-14 |
Kingsley Stuart A Director · Common Stock · 2026-05-13 | Grant | 6.52K | $0 | 2026-05-13 | 2026-05-14 |
Humphreys Keith Director · Common Stock · 2026-05-13 | Grant | 6.52K | $0 | 2026-05-13 | 2026-05-14 |
Ryan Barbara Director · Common Stock · 2026-05-13 | Grant | 6.52K | $0 | 2026-05-13 | 2026-05-14 |
NINIVAGGI DANIEL A Director · Common Stock · 2026-05-13 | Grant | 6.52K | $0 | 2026-05-13 | 2026-05-14 |
Wheadon David E. Director · Common Stock · 2026-05-13 | Grant | 10.43K | $0 | 2026-05-13 | 2026-05-14 |
SEC filings
EDGAR filings in INDV · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.